Diagnostic performance of (18)F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer

PURPOSE: The introduction of ligands targeting prostate-specific membrane antigen (PSMA), especially (68)Ga-PSMA-11, has changed the management of patients with prostate cancer (PCa). (18)F-Labelled ligands can be produced in larger amounts and therefore can improve availability for a larger group o...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahbar, Kambiz, Afshar-Oromieh, Ali, Seifert, Robert, Wagner, Stefan, Schäfers, Michael, Bögemann, Martin, Weckesser, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182394/
https://www.ncbi.nlm.nih.gov/pubmed/30027419
http://dx.doi.org/10.1007/s00259-018-4089-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182394/
https://www.ncbi.nlm.nih.gov/pubmed/30027419
http://dx.doi.org/10.1007/s00259-018-4089-x

Ejemplares similares